Reasons for polypharmacy among psychiatric patients

Réka Viola, Katalin Csukonyi, Péter Doró, Z. Janka, Gyöngyvér Soós

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Introduction: Increasing attention has recently been focused on polypharmacy, which is often referred to as an indicator of irrational drug consumption. Although polypharmacy is an important risk factor for problems arising from drug therapies, certain health concerns and conditions or patient-specific factors may justify the need for polypharmacy. In recent years there no data have been published regarding polypharmacy in Hungary. Objective: The authors examined the frequency of polypharmacy among psychiatric patients. The study also looked at the extent to which comorbidity and demographic characteristics (age, gender) were responsible for the multiple drug use. Methods: An inpatient database of the year 2001 at the psychiatric department was analysed. Based on the standard definition of polypharmacy the authors enrolled into the polypharmacy group those patients who were on more than five drugs as part of chronic and simultaneous therapy. The data were analysed with the SPSS 9.0 statistics program package. Results: Among the psychiatric patients included in the study (N = 984) the frequency of polypharmacy was 33.6%. Significant correlation was found between the investigated factors (age, gender, comorbidity) and polypharmacy. On the basis of OR-values, comorbidity was the strongest inducer of polypharmacy. Conclusion: Polypharmacy cannot be fundamentally regarded as unnecessary drug use. Numerous facts prove that in certain diseases and conditions adequate polypharmacy is necessary.

Original languageEnglish
Pages (from-to)143-147
Number of pages5
JournalPharmacy World and Science
Volume26
Issue number3
DOIs
Publication statusPublished - Jun 2004

Fingerprint

Polypharmacy
Psychiatry
Pharmaceutical Preparations
Drug therapy
Comorbidity
Health
Statistics
Hungary
Age Factors
Inpatients

Keywords

  • Comorbidity
  • Drug use
  • Hungary
  • Polypharmacy
  • Psychiatric patients
  • Psychiatry

ASJC Scopus subject areas

  • Chemistry(all)
  • Pharmaceutical Science
  • Pharmacology

Cite this

Reasons for polypharmacy among psychiatric patients. / Viola, Réka; Csukonyi, Katalin; Doró, Péter; Janka, Z.; Soós, Gyöngyvér.

In: Pharmacy World and Science, Vol. 26, No. 3, 06.2004, p. 143-147.

Research output: Contribution to journalArticle

Viola, Réka ; Csukonyi, Katalin ; Doró, Péter ; Janka, Z. ; Soós, Gyöngyvér. / Reasons for polypharmacy among psychiatric patients. In: Pharmacy World and Science. 2004 ; Vol. 26, No. 3. pp. 143-147.
@article{27f4d1f236a14782843a6005a2eaa367,
title = "Reasons for polypharmacy among psychiatric patients",
abstract = "Introduction: Increasing attention has recently been focused on polypharmacy, which is often referred to as an indicator of irrational drug consumption. Although polypharmacy is an important risk factor for problems arising from drug therapies, certain health concerns and conditions or patient-specific factors may justify the need for polypharmacy. In recent years there no data have been published regarding polypharmacy in Hungary. Objective: The authors examined the frequency of polypharmacy among psychiatric patients. The study also looked at the extent to which comorbidity and demographic characteristics (age, gender) were responsible for the multiple drug use. Methods: An inpatient database of the year 2001 at the psychiatric department was analysed. Based on the standard definition of polypharmacy the authors enrolled into the polypharmacy group those patients who were on more than five drugs as part of chronic and simultaneous therapy. The data were analysed with the SPSS 9.0 statistics program package. Results: Among the psychiatric patients included in the study (N = 984) the frequency of polypharmacy was 33.6{\%}. Significant correlation was found between the investigated factors (age, gender, comorbidity) and polypharmacy. On the basis of OR-values, comorbidity was the strongest inducer of polypharmacy. Conclusion: Polypharmacy cannot be fundamentally regarded as unnecessary drug use. Numerous facts prove that in certain diseases and conditions adequate polypharmacy is necessary.",
keywords = "Comorbidity, Drug use, Hungary, Polypharmacy, Psychiatric patients, Psychiatry",
author = "R{\'e}ka Viola and Katalin Csukonyi and P{\'e}ter Dor{\'o} and Z. Janka and Gy{\"o}ngyv{\'e}r So{\'o}s",
year = "2004",
month = "6",
doi = "10.1023/B:PHAR.0000026800.13888.b0",
language = "English",
volume = "26",
pages = "143--147",
journal = "International Journal of Clinical Pharmacy",
issn = "2210-7703",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Reasons for polypharmacy among psychiatric patients

AU - Viola, Réka

AU - Csukonyi, Katalin

AU - Doró, Péter

AU - Janka, Z.

AU - Soós, Gyöngyvér

PY - 2004/6

Y1 - 2004/6

N2 - Introduction: Increasing attention has recently been focused on polypharmacy, which is often referred to as an indicator of irrational drug consumption. Although polypharmacy is an important risk factor for problems arising from drug therapies, certain health concerns and conditions or patient-specific factors may justify the need for polypharmacy. In recent years there no data have been published regarding polypharmacy in Hungary. Objective: The authors examined the frequency of polypharmacy among psychiatric patients. The study also looked at the extent to which comorbidity and demographic characteristics (age, gender) were responsible for the multiple drug use. Methods: An inpatient database of the year 2001 at the psychiatric department was analysed. Based on the standard definition of polypharmacy the authors enrolled into the polypharmacy group those patients who were on more than five drugs as part of chronic and simultaneous therapy. The data were analysed with the SPSS 9.0 statistics program package. Results: Among the psychiatric patients included in the study (N = 984) the frequency of polypharmacy was 33.6%. Significant correlation was found between the investigated factors (age, gender, comorbidity) and polypharmacy. On the basis of OR-values, comorbidity was the strongest inducer of polypharmacy. Conclusion: Polypharmacy cannot be fundamentally regarded as unnecessary drug use. Numerous facts prove that in certain diseases and conditions adequate polypharmacy is necessary.

AB - Introduction: Increasing attention has recently been focused on polypharmacy, which is often referred to as an indicator of irrational drug consumption. Although polypharmacy is an important risk factor for problems arising from drug therapies, certain health concerns and conditions or patient-specific factors may justify the need for polypharmacy. In recent years there no data have been published regarding polypharmacy in Hungary. Objective: The authors examined the frequency of polypharmacy among psychiatric patients. The study also looked at the extent to which comorbidity and demographic characteristics (age, gender) were responsible for the multiple drug use. Methods: An inpatient database of the year 2001 at the psychiatric department was analysed. Based on the standard definition of polypharmacy the authors enrolled into the polypharmacy group those patients who were on more than five drugs as part of chronic and simultaneous therapy. The data were analysed with the SPSS 9.0 statistics program package. Results: Among the psychiatric patients included in the study (N = 984) the frequency of polypharmacy was 33.6%. Significant correlation was found between the investigated factors (age, gender, comorbidity) and polypharmacy. On the basis of OR-values, comorbidity was the strongest inducer of polypharmacy. Conclusion: Polypharmacy cannot be fundamentally regarded as unnecessary drug use. Numerous facts prove that in certain diseases and conditions adequate polypharmacy is necessary.

KW - Comorbidity

KW - Drug use

KW - Hungary

KW - Polypharmacy

KW - Psychiatric patients

KW - Psychiatry

UR - http://www.scopus.com/inward/record.url?scp=3543029836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3543029836&partnerID=8YFLogxK

U2 - 10.1023/B:PHAR.0000026800.13888.b0

DO - 10.1023/B:PHAR.0000026800.13888.b0

M3 - Article

C2 - 15230361

AN - SCOPUS:3543029836

VL - 26

SP - 143

EP - 147

JO - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 2210-7703

IS - 3

ER -